Oric Pharmaceuticals, Inc. ORIC Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$135.21M-4.4% | -$129.47M+4.3% | -$135.27M+1.4% | -$137.25M-3.3% | -$132.86M-3.9% | ||
| $1.19M-2.6% | $1.22M+1.3% | $1.2M+1.5% | $1.19M+3.3% | $1.15M+3.7% | ||
| $25.38M+1.4% | $25.04M+4.5% | $23.96M+2.5% | $23.39M+7.2% | $21.81M+7.9% | ||
| -$110.88M+0.1% | -$110.97M+4.8% | -$116.54M+3.1% | -$120.23M-4.5% | -$115.01M-2.1% | ||
| $327K-54.1% | $712K+1.1% | $704K-35.2% | $1.09M-19.9% | $1.36M+14.2% | ||
| —— | —— | -$122.36M— | —— | —— | ||
| $306.39M+24.9% | $245.26M+0.4% | $244.34M+81.0% | $135.01M+8,736% | $1.53M-98.8% | ||
| $7.06M+151% | -$13.74M-353% | $5.44M— | —— | —— | ||
| -$111.2M+0.4% | -$111.68M+4.7% | -$117.25M+3.4% | -$121.31M-4.3% | -$116.37M-2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Oric Pharmaceuticals, Inc. generate?
- Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.
- What is Oric Pharmaceuticals, Inc.'s free cash flow?
- After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.
- Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.